PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG)
Research payments
$65,349
Through program year 2023, $65,349 in research payments was reported against PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG), across 81 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $995 | 4 |
| 2022 | Research | $59,834 | 72 |
| 2021 | Research | $4,520 | 5 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nestor Tomycz Washington, PA Named on 7 payments
- David Schultz Edina, MN Named on 7 payments
- Krishnan Chakravarthy San Diego, CA Named on 6 payments
- Anthony Hadden Bend, OR Named on 5 payments
- Nathan Miller Carlsbad, CA Named on 5 payments
- Jason Pope Santa Rosa, CA Named on 4 payments
- Steven Falowski Fountain Hill, PA Named on 4 payments
- Fotios Vrionis Boca Raton, FL Named on 4 payments
- Corey Hunter New York, NY Named on 4 payments
- Patrick Buchanan Camarillo, CA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.